Other bladder disorders
Conditions
Interventions
It is a randomized, blinded clinical trial.
Children will be allocated to one of the two groups by means of a randomization using opaque and sealed envelopes with sequential numbering obtained by comp
correct posture to the toilet with the trunk slightly flexed at the time of urination and / or defecation, using, when necessary, a reducer in the toilet and a foot support to facilitate abdominal pre
avoiding coffee, tea, soda, chocolate and citrus fruits during treatment
urinate before bed
ingest more fluid during the day
not to retain urine when urinating, to eat high-fiber foods.
Surface Electrodes: A square, symmetrical biphasic current with a frequency of 10 Hz, a pulse width of 700 Hz will be used and the intensit
Behavioural
Other
E02.331.800
Sponsors
Glicia Estevam de Abreu
Escola Bahiana de Medicina e Saúde Peública
Eligibility
Age
5 Years to 17 Years
Inclusion criteria
Inclusion criteria: Children and adolescents aged 05 to 17 years with vesicoureteral dysfunction
Exclusion criteria
Exclusion criteria: Patients and / or caregivers who give up participating in the study after being included. Patients who do not perform all the exams established in the care protocol. Later diagnosis of neurological and anatomical alterations of the gastrointestinal tract and inferior urinary tract. If signs of hidden spina bifida or any other neurological abnormalities are identified on the physical examination of the lumbosacral spine, patients will be referred for a specialist investigation. Patients with any change in urine summary such as glycosuria or osmolarity disorder, such as in diabetic mellitus and insipidus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of urinary symptoms measured by the Toronto score (score less than 6 for boys and less than 9 for girls), clinical improvement of constipation measured by the frequency of exits (more than 3 exits per week) and less than 02 criteria of Rome IV, complete bowel movement defined as complete evacuation sensation (more than 3 per week). | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in symptoms associated with constipation: pain abdominal, stool strength, abdominal distention and stool consistency, improvement of fecal incontinence, (Urofluxometry, bladder capacity, post-voiding residue, thickness of the bladder wall), Decreased rectal diameter, decreased urine output, Improved growth (weight gain), Improvement in quality of life (numbers of patients with improvement in quality of life, change in own-perception of quality of life and change in the perception of improvement of the quality of life by relatives). | — |
Countries
Brazil
Contacts
Public ContactGlicia Abreu
Escola Bahiana de Medicina e Saúde Peública
Outcome results
None listed